Longitudinal study of factors associated with the anti-cancer efficacy and liver function in HCC patients treated with TACE in combination with percutaneous ablation
The combination of TACE and percutaneous ablation enhances outcomes in HCC, guided by specific prognostic markers. This supports the need for personalized approaches in HCC treatment and further research into combination therapies.
Authors
- Hongliang Ren (ORCID: https://orcid.org/0000-0002-6488-1551)
- Zhiqun Wu (ORCID: https://orcid.org/0000-0001-5881-921X)
- Jian Chen (ORCID: https://orcid.org/0000-0003-4234-2028)
- Chen Li (ORCID: https://orcid.org/0000-0002-0905-4297)
Institutions
- Xi'an Honghui Hospital (CN)
- Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-04-16
- DOI
- https://doi.org/10.3389/fonc.2025.1566865
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32